AIM 3: Anemia and Iron Management With Every 3 Week Dosing in Anemic Subjects With Nonmyeloid Malignancies
Clinical trial NCT00135317 · COMPLETED
Trial details
- NCT number
- NCT00135317
- Sponsor
- Amgen
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2004-11-01
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.